These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
611 related items for PubMed ID: 21377506
1. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer. Chan DS, Yang H, Kwan MH, Cheng Z, Lee P, Bai LP, Jiang ZH, Wong CY, Fong WF, Leung CH, Ma DL. Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506 [Abstract] [Full Text] [Related]
2. Structure-based design of flavone derivatives as c-myc oncogene down-regulators. Yang H, Zhong HJ, Leung KH, Chan DS, Ma VP, Fu WC, Nanjunda R, Wilson WD, Ma DL, Leung CH. Eur J Pharm Sci; 2013 Jan 23; 48(1-2):130-41. PubMed ID: 23127826 [Abstract] [Full Text] [Related]
3. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA. Wang P, Leung CH, Ma DL, Yan SC, Che CM. Chemistry; 2010 Jun 18; 16(23):6900-11. PubMed ID: 20437426 [Abstract] [Full Text] [Related]
4. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression. Wu P, Ma DL, Leung CH, Yan SC, Zhu N, Abagyan R, Che CM. Chemistry; 2009 Dec 07; 15(47):13008-21. PubMed ID: 19876976 [Abstract] [Full Text] [Related]
5. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc. Ma Y, Ou TM, Hou JQ, Lu YJ, Tan JH, Gu LQ, Huang ZS. Bioorg Med Chem; 2008 Aug 15; 16(16):7582-91. PubMed ID: 18674916 [Abstract] [Full Text] [Related]
6. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands. Chen WJ, Zhou CX, Yao PF, Wang XX, Tan JH, Li D, Ou TM, Gu LQ, Huang ZS. Bioorg Med Chem; 2012 May 01; 20(9):2829-36. PubMed ID: 22484007 [Abstract] [Full Text] [Related]
7. 12-N-Methylated 5,6-dihydrobenzo[c]acridine derivatives: a new class of highly selective ligands for c-myc G-quadruplex DNA. Liao SR, Zhou CX, Wu WB, Ou TM, Tan JH, Li D, Gu LQ, Huang ZS. Eur J Med Chem; 2012 Jul 01; 53():52-63. PubMed ID: 22513122 [Abstract] [Full Text] [Related]
8. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives. Ou TM, Lu YJ, Zhang C, Huang ZS, Wang XD, Tan JH, Chen Y, Ma DL, Wong KY, Tang JC, Chan AS, Gu LQ. J Med Chem; 2007 Apr 05; 50(7):1465-74. PubMed ID: 17346034 [Abstract] [Full Text] [Related]
9. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder. Kang HJ, Park HJ. Biochemistry; 2009 Aug 11; 48(31):7392-8. PubMed ID: 19496619 [Abstract] [Full Text] [Related]
10. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative. Zhang Z, He X, Yuan G. Int J Biol Macromol; 2011 Dec 01; 49(5):1173-6. PubMed ID: 21683090 [Abstract] [Full Text] [Related]
11. Quinolino-benzo-[5, 6]-dihydroisoquindolium compounds derived from berberine: a new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene. Ma Y, Ou TM, Tan JH, Hou JQ, Huang SL, Gu LQ, Huang ZS. Eur J Med Chem; 2011 May 01; 46(5):1906-13. PubMed ID: 21392861 [Abstract] [Full Text] [Related]
12. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex. Ou TM, Lin J, Lu YJ, Hou JQ, Tan JH, Chen SH, Li Z, Li YP, Li D, Gu LQ, Huang ZS. J Med Chem; 2011 Aug 25; 54(16):5671-9. PubMed ID: 21774525 [Abstract] [Full Text] [Related]
13. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells. Nagesh N, Raju G, Srinivas R, Ramesh P, Reddy MD, Reddy ChR. Biochim Biophys Acta; 2015 Jan 25; 1850(1):129-40. PubMed ID: 25452213 [Abstract] [Full Text] [Related]
14. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH. Proc Natl Acad Sci U S A; 2002 Sep 03; 99(18):11593-8. PubMed ID: 12195017 [Abstract] [Full Text] [Related]
15. Furan based cyclic homo-oligopeptides bind G-quadruplex selectively and repress c-MYC transcription. Agarwal T, Roy S, Chakraborty TK, Maiti S. Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4346-9. PubMed ID: 20615700 [Abstract] [Full Text] [Related]
16. 4-(1H-imidazo[4,5-f]-1,10-phenanthrolin-2-yl)phenol-based G-quadruplex DNA binding agents: telomerase inhibition, cytotoxicity and DNA-binding studies. Wei CY, Wang JH, Wen Y, Liu J, Wang LH. Bioorg Med Chem; 2013 Jun 01; 21(11):3379-87. PubMed ID: 23611765 [Abstract] [Full Text] [Related]
17. C-11 diamino cryptolepine derivatives NSC748392, NSC748393, and NSC748394: anticancer profile and G-quadruplex stabilization. Lavrado J, Reszka AP, Moreira R, Neidle S, Paulo A. Bioorg Med Chem Lett; 2010 Dec 01; 20(23):7042-5. PubMed ID: 20952194 [Abstract] [Full Text] [Related]
18. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter. Yin F, Liu J, Deng X, Wang J. J Biochem; 2007 May 01; 141(5):669-74. PubMed ID: 17339229 [Abstract] [Full Text] [Related]
19. Selective targeting of G-quadruplex using furan-based cyclic homooligopeptides: effect on c-MYC expression. Agarwal T, Roy S, Chakraborty TK, Maiti S. Biochemistry; 2010 Sep 28; 49(38):8388-97. PubMed ID: 20712380 [Abstract] [Full Text] [Related]
20. Bisaryldiketene derivatives: A new class of selective ligands for c-myc G-quadruplex DNA. Peng D, Tan JH, Chen SB, Ou TM, Gu LQ, Huang ZS. Bioorg Med Chem; 2010 Dec 01; 18(23):8235-42. PubMed ID: 21036049 [Abstract] [Full Text] [Related] Page: [Next] [New Search]